These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 27320895)
21. Serum Lp-PLA2 Level Predicting Coronary Artery Lesions in Children with Kawasaki Disease. Zhang X; Ya-Wang Shao ; Ya-Lan Zhang ; Yi Liu Heart Surg Forum; 2021 Jul; 24(4):E611-E618. PubMed ID: 34473042 [TBL] [Abstract][Full Text] [Related]
22. Causal effect of Lipoprotein-associated phospholipase A2 activity on coronary artery disease and myocardial Infarction: A Two-Sample Mendelian Randomization study. Sun L; Zhu Z; Shi M; Jia Y; Yang P; Wang Y; Liu F; Zhang Y Clin Chim Acta; 2021 Dec; 523():491-496. PubMed ID: 34740601 [TBL] [Abstract][Full Text] [Related]
23. Lipoprotein-associated phospholipase A2 activity predicts cardiovascular events in high risk coronary artery disease patients. Maiolino G; Pedon L; Cesari M; Frigo AC; Wolfert RL; Barisa M; Pagliani L; Rossitto G; Seccia TM; Zanchetta M; Rossi GP PLoS One; 2012; 7(10):e48171. PubMed ID: 23118945 [TBL] [Abstract][Full Text] [Related]
24. Evaluation of lipoprotein-associated phosholipase A2 and plaque burden/composition in young adults. Celik O; Ozturk D; Akin F; Satilmis S; Yalcin AA; Erturk M; Ayca B; Akturk F; Birand A; Pusuroglu H; Kaya MG Coron Artery Dis; 2015 May; 26(3):266-71. PubMed ID: 25647459 [TBL] [Abstract][Full Text] [Related]
25. Association between serum lipoprotein-associated phospholipase A2, ischemic modified albumin and acute coronary syndrome: a cross-sectional study. Yang F; Ma L; Zhang L; Wang Y; Zhao C; Zhu W; Liang W; Liu Q Heart Vessels; 2019 Oct; 34(10):1608-1614. PubMed ID: 30963302 [TBL] [Abstract][Full Text] [Related]
26. Lipoprotein-associated phospholipase A2 predicts progression of cardiac allograft vasculopathy and increased risk of cardiovascular events in heart transplant patients. Raichlin E; McConnell JP; Bae JH; Kremers WK; Lerman A; Frantz RP Transplantation; 2008 Apr; 85(7):963-8. PubMed ID: 18408575 [TBL] [Abstract][Full Text] [Related]
27. Lipoprotein-associated phospholipase A2 levels are associated with erectile dysfunction in patients without known coronary artery disease. Otunctemur A; Sahin S; Ozbek E; Cekmen M; İnal A; Tulubas F; Dursun M; Besiroglu H; Koklu I Andrologia; 2015 Aug; 47(6):706-10. PubMed ID: 25091174 [TBL] [Abstract][Full Text] [Related]
28. Association between Lp-PLA2 and coronary artery disease: focus on its relationship with lipoproteins and markers of inflammation and hemostasis. Khuseyinova N; Imhof A; Rothenbacher D; Trischler G; Kuelb S; Scharnagl H; Maerz W; Brenner H; Koenig W Atherosclerosis; 2005 Sep; 182(1):181-8. PubMed ID: 16115490 [TBL] [Abstract][Full Text] [Related]
29. Lipoprotein phospholipase A2 in patients with isolated coronary artery ectasia. Korkmaz L; Erkuş E; Kırış A; Ağaç MT; Acar Z; Turan T; Erkan H; Dursun I; Celik S Clin Res Cardiol; 2011 Jun; 100(6):511-4. PubMed ID: 21207044 [TBL] [Abstract][Full Text] [Related]
30. Correlation of red cell distribution width with the severity of coronary artery disease: a large Chinese cohort study from a single center. Ma FL; Li S; Li XL; Liu J; Qing P; Guo YL; Xu RX; Zhu CG; Jia YJ; Liu G; Dong Q; Wu NQ; Jiang LX; Li JJ Chin Med J (Engl); 2013 Mar; 126(6):1053-7. PubMed ID: 23506577 [TBL] [Abstract][Full Text] [Related]
32. Lipoprotein-associated phospholipase A2 is related to risk of subclinical atherosclerosis but is not supported by Mendelian randomization analysis in a general Japanese population. Ueshima H; Kadowaki T; Hisamatsu T; Fujiyoshi A; Miura K; Ohkubo T; Sekikawa A; Kadota A; Kadowaki S; Nakamura Y; Miyagawa N; Okamura T; Kita Y; Takashima N; Kashiwagi A; Maegawa H; Horie M; Yamamoto T; Kimura T; Kita T; Atherosclerosis; 2016 Mar; 246():141-7. PubMed ID: 26775119 [TBL] [Abstract][Full Text] [Related]
33. Is lipoprotein-associated phospholipase A2 activity correlated with fibrous-cap thickness and plaque volume in patients with acute coronary syndrome? Gu X; Hou J; Yang S; Yu H; Tian J; Liu F; Li N; Yu B; Jang IK Coron Artery Dis; 2014 Jan; 25(1):10-5. PubMed ID: 24089018 [TBL] [Abstract][Full Text] [Related]
34. Predictive value of combining the level of lipoprotein-associated phospholipase A2 and antithrombin III for acute coronary syndrome risk. Lu J; Niu D; Zheng D; Zhang Q; Li W Biomed Rep; 2018 Dec; 9(6):517-522. PubMed ID: 30546880 [TBL] [Abstract][Full Text] [Related]
35. Polyunsaturated omega-3 fatty acids reduce lipoprotein-associated phospholipase A(2) in patients with stable angina. Gajos G; Zalewski J; Mostowik M; Konduracka E; Nessler J; Undas A Nutr Metab Cardiovasc Dis; 2014 Apr; 24(4):434-9. PubMed ID: 24555913 [TBL] [Abstract][Full Text] [Related]
37. Combined Assessment of Elevated Plasma Lipoprotein-Associated Phospholipase A Yan X; Gao J; Tang M; Zhang D; Li L; Wang L; Lei X; Zhang X J Stroke Cerebrovasc Dis; 2021 Dec; 30(12):106103. PubMed ID: 34587576 [TBL] [Abstract][Full Text] [Related]
38. Relationship between high-density lipoprotein cholesterol and the red cell distribution width in patients with coronary artery disease. Avci E; Kiris T; Demirtas AO; Kadi H Lipids Health Dis; 2018 Mar; 17(1):53. PubMed ID: 29548288 [TBL] [Abstract][Full Text] [Related]
39. Correlation of plasma galectin-3 and plasma lipoprotein-associated phospholipase A2 with the severity and prognosis of coronary artery disease. Wang R; Wang X; Zhang E; Li F; Zhang P; Shi J Am J Transl Res; 2021; 13(8):8997-9004. PubMed ID: 34540011 [TBL] [Abstract][Full Text] [Related]
40. Relation of red cell distribution width with the presence, severity, and complexity of coronary artery disease. Isik T; Uyarel H; Tanboga IH; Kurt M; Ekinci M; Kaya A; Ayhan E; Ergelen M; Bayram E; Gibson CM Coron Artery Dis; 2012 Jan; 23(1):51-6. PubMed ID: 22133925 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]